227 related articles for article (PubMed ID: 31175644)
41. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
[TBL] [Abstract][Full Text] [Related]
42. Re-entering the pluripotent state from blood lineage: promises and pitfalls of blood reprogramming.
Chen Y; Yi Y; Xu J; Chan WK; Loh YH
FEBS Lett; 2019 Dec; 593(23):3244-3252. PubMed ID: 31691960
[TBL] [Abstract][Full Text] [Related]
43. GATA2 deficiency and human hematopoietic development modeled using induced pluripotent stem cells.
Jung M; Cordes S; Zou J; Yu SJ; Guitart X; Hong SG; Dang V; Kang E; Donaires FS; Hassan SA; Albitar M; Hsu AP; Holland SM; Hickstein DD; Townsley D; Dunbar CE; Winkler T
Blood Adv; 2018 Dec; 2(23):3553-3565. PubMed ID: 30538114
[TBL] [Abstract][Full Text] [Related]
44. Modeling myeloid malignancies with patient-derived iPSCs.
Papapetrou EP
Exp Hematol; 2019 Mar; 71():77-84. PubMed ID: 30481543
[TBL] [Abstract][Full Text] [Related]
45. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.
Sridhar A; Ohlemacher SK; Langer KB; Meyer JS
Stem Cells Transl Med; 2016 Apr; 5(4):417-26. PubMed ID: 26933039
[TBL] [Abstract][Full Text] [Related]
46. Generation of HIV-1 resistant and functional macrophages from hematopoietic stem cell-derived induced pluripotent stem cells.
Kambal A; Mitchell G; Cary W; Gruenloh W; Jung Y; Kalomoiris S; Nacey C; McGee J; Lindsey M; Fury B; Bauer G; Nolta JA; Anderson JS
Mol Ther; 2011 Mar; 19(3):584-93. PubMed ID: 21119622
[TBL] [Abstract][Full Text] [Related]
47. Derivation of Skeletal Myogenic Precursors from Human Pluripotent Stem Cells Using Conditional Expression of PAX7.
Darabi R; Perlingeiro RC
Methods Mol Biol; 2016; 1357():423-39. PubMed ID: 25403466
[TBL] [Abstract][Full Text] [Related]
48. Inability of human induced pluripotent stem cell-hematopoietic derivatives to downregulate microRNAs in vivo reveals a block in xenograft hematopoietic regeneration.
Risueño RM; Sachlos E; Lee JH; Lee JB; Hong SH; Szabo E; Bhatia M
Stem Cells; 2012 Feb; 30(2):131-9. PubMed ID: 22131151
[TBL] [Abstract][Full Text] [Related]
49. Generation of Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells.
Oguro H
Methods Mol Biol; 2019; 2048():245-257. PubMed ID: 31396942
[TBL] [Abstract][Full Text] [Related]
50. Antagonism of PPAR-γ signaling expands human hematopoietic stem and progenitor cells by enhancing glycolysis.
Guo B; Huang X; Lee MR; Lee SA; Broxmeyer HE
Nat Med; 2018 Mar; 24(3):360-367. PubMed ID: 29377004
[TBL] [Abstract][Full Text] [Related]
51. Parallel assessment of globin lentiviral transfer in induced pluripotent stem cells and adult hematopoietic stem cells derived from the same transplanted β-thalassemia patient.
Tubsuwan A; Abed S; Deichmann A; Kardel MD; Bartholomä C; Cheung A; Negre O; Kadri Z; Fucharoen S; von Kalle C; Payen E; Chrétien S; Schmidt M; Eaves CJ; Leboulch P; Maouche-Chrétien L
Stem Cells; 2013 Sep; 31(9):1785-94. PubMed ID: 23712774
[TBL] [Abstract][Full Text] [Related]
52. Development of patient-specific hematopoietic stem and progenitor cell grafts from pluripotent stem cells, in vitro.
Klump H; Teichweyde N; Meyer C; Horn PA
Curr Mol Med; 2013 Jun; 13(5):815-20. PubMed ID: 23642062
[TBL] [Abstract][Full Text] [Related]
53. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
[TBL] [Abstract][Full Text] [Related]
54. Progresses in overcoming the limitations of in vitro erythropoiesis using human induced pluripotent stem cells.
Ju H; Sohn Y; Nam Y; Rim YA
Stem Cell Res Ther; 2024 May; 15(1):142. PubMed ID: 38750578
[TBL] [Abstract][Full Text] [Related]
55. Development of Individualized Induced Pluripotent Stem Cells From Fibroblasts of Keloid Lesions in Patients.
Zhang YX; Liu LP; Li M; Huang JL; Xu H; Chen XD; Zhu WY; Cai YP; Guo NN; Chen ZQ; Zheng YW; Li YM
Transplant Proc; 2018 Nov; 50(9):2868-2871. PubMed ID: 30401414
[TBL] [Abstract][Full Text] [Related]
56. Modulation of WNT, Activin/Nodal, and MAPK Signaling Pathways Increases Arterial Hemogenic Endothelium and Hematopoietic Stem/Progenitor Cell Formation During Human iPSC Differentiation.
Li Y; Ding J; Araki D; Zou J; Larochelle A
Stem Cells; 2023 Jul; 41(7):685-697. PubMed ID: 37220178
[TBL] [Abstract][Full Text] [Related]
57. High-Throughput Screening of Senescence Markers in Hematopoietic Stem Cells Derived from Induced Pluripotent Stem Cells.
Jose SS; Bendickova K; Fric J
Methods Mol Biol; 2018; 1771():121-130. PubMed ID: 29633209
[TBL] [Abstract][Full Text] [Related]
58. Pyrimidoindole derivative UM171 enhances derivation of hematopoietic progenitor cells from human pluripotent stem cells.
Li X; Xia C; Wang T; Liu L; Zhao Q; Yang D; Hu F; Zhang M; Huang K; Geng Y; Zheng Y; Guan Y; Wu H; Chen X; Pan G; Chen J; Du J; Wang J
Stem Cell Res; 2017 May; 21():32-39. PubMed ID: 28368243
[TBL] [Abstract][Full Text] [Related]
59. Techniques of Human Embryonic Stem Cell and Induced Pluripotent Stem Cell Derivation.
Lewandowski J; Kurpisz M
Arch Immunol Ther Exp (Warsz); 2016 Oct; 64(5):349-70. PubMed ID: 26939778
[TBL] [Abstract][Full Text] [Related]
60. The RUNX1 +24 enhancer and P1 promoter identify a unique subpopulation of hematopoietic progenitor cells derived from human pluripotent stem cells.
Ferrell PI; Xi J; Ma C; Adlakha M; Kaufman DS
Stem Cells; 2015 Apr; 33(4):1130-41. PubMed ID: 25546363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
